Miller Anestesia

720

Farmacología y anestesia

85. Fullerton DA, Jones SD, Jaggers J, et al: Effective

control of pulmonary vascular resistance with

inhaled nitric oxide after cardiac operation.J Thorac

Cardiovasc Surg 111:753-762, 1996.

86. Fullerton DA,Jaggers J,Wollmering MM,et al:Varia-

ble response to inhaled nitric oxide after cardiac

surgery. Ann Thorac Surg 63:1251-1256, 1997.

87. Lindberg L, Larsson A, Steen S, et al: Nitric oxide

gives maximal response after coronary artery bypass

surgery. J Cardiothorac Vasc Anesth 8:182-187,

1994.

88. Wheller J, George BL, Mulder DG, Jarmakani JM:

Diagnosis and management of postoperative pul-

monary hypertensive crisis. Circulation 60:1640-

1644, 1979.

89. Hopkins RA, Bull C, Haworth SG, et al: Pulmonary

hypertensive crises following surgery for congenital

heart defects in young children. Eur J Cardiothorac

Surg 5:628-634, 1991.

90. Wessel DL,Adatia I, Giglia TM, et al: Use of inhaled

nitric oxide and acetylcholine in the evaluation of

pulmonary hypertension and endothelial function

after cardiopulmonary bypass. Circulation 88:2128-

2138, 1993.

91. Roberts JD Jr, Lang P, Bigatello LM, et al: Inhaled

nitric oxide in congenital heart disease. Circulation

87:447-453, 1993.

92. Russell IA, Zwass MS, Fineman JR, et al: The effects

of inhaled nitric oxide on postoperative pulmonary

hypertension in infants and children undergoing

surgical repair of congenital heart disease. Anesth

Analg 87:46-51, 1998.

93. Goldman AP, Delius RE, Deanfield JE, et al: Phar-

macological control of pulmonary blood flow with

inhaled nitric oxide after the fenestrated Fontan

operation. Circulation 94:II44-II48, 1996.

94. Miller OI, Tang SF, Keech A, et al: Inhaled nitric

oxide and prevention of pulmonary hypertension

after congenital heart surgery: A randomised

double-blind study. Lancet 356:1464-1469, 2000.

95. Rich GF, Murphy GD Jr, Roos CM, Johns RA:

Inhaled nitric oxide. Selective pulmonary vasodila-

tion in cardiac surgical patients. Anesthesiology

78:1028-1035, 1993.

96. Mahoney PD, Loh E, Blitz LR, Herrmann HC:

Hemodynamic effects of inhaled nitric oxide in

women with mitral stenosis and pulmonary hyper-

tension. Am J Cardiol 87:188-192, 2001.

97. Stobierska-Dzierzek B, Awad H, Michler RE: The

evolving management of acute right-sided heart

failure in cardiac transplant recipients. J Am Coll

Cardiol 38:923-931, 2001.

98. Ardehali A, Hughes K, Sadeghi A, et al: Inhaled

nitric oxide for pulmonary hypertension after heart

transplantation. Transplantation 72:638-641, 2001.

99. Fojon S, Fernandez-Gonzalez C, Sanchez-Andrade

J, et al: Inhaled nitric oxide through a noninvasive

ventilation device to assess reversibility of pulmo-

nary hypertension in selecting recipients for heart

transplant. Transplant Proc 37:4028-4030, 2005.

100. Frazier OH, Rose EA, Macmanus Q, et al: Multicen-

ter clinical evaluation of the HeartMate 1000 IP left

ventricular assist device. Ann Thorac Surg 53:1080-

1090, 1992.

101. Macdonald PS, Keogh A, Mundy J, et al: Adjunctive

use of inhaled nitric oxide during implantation of a

left ventricular assist device. J Heart Lung Trans-

plant 17:312-316, 1998.

102. Yahagi N, Kumon K, Nakatani T, et al: Inhaled nitric

oxide for the management of acute right ventricular

failure in patients with a left ventricular assist

system. Artif Organs 19:557-558, 1995.

103. Argenziano M, Choudhri AF, Moazami N, et al:

Randomized, double-blind trial of inhaled nitric

oxide in LVAD recipients with pulmonary hyper-

tension. Ann Thorac Surg 65:340-345, 1998.

104. Struber M, Harringer W, Ernst M, et al: Inhaled

nitric oxide as a prophylactic treatment against

reperfusion injury of the lung. Thorac Cardiovasc

Surg 47:179-182, 1999.

105. Date H, Triantafillou AN, Trulock EP, et al: Inhaled

nitric oxide reduces human lung allograft dys-

function. J Thorac Cardiovasc Surg 111:913-919,

1996.

106. Ardehali A, Laks H, Levine M, et al: A prospective

trial of inhaled nitric oxide in clinical lung trans-

plantation. Transplantation 72:112-115, 2001.

107. Meade MO, Granton JT, Matte-Martyn A, et al: A

randomized trial of inhaled nitric oxide to prevent

ischemia-reperfusion injury after lung transplanta-

tion. Am J Respir Crit Care Med 167:1483-1489,

2003.

108. Ichinose F, Adrie C, Hurford WE, Zapol WM: Pro-

longed pulmonary vasodilator action of inhaled

nitric oxide by zaprinast in awake lambs. J Appl

Physiol 78:1288-1295, 1995.

109. Thusu KG, Morin FC III, Russell JA, Steinhorn RH:

The cGMP phosphodiesterase inhibitor zaprinast

enhances the effect of nitric oxide.Am J Respir Crit

Care Med 152:1605-1610, 1995.

110. Ichinose F, Adrie C, Hurford WE, et al: Selective

pulmonary vasodilation induced by aerosolized

zaprinast. Anesthesiology 88:410-416, 1998.

111. Ichinose F, Erana-Garcia J, Hromi J, et al: Nebulized

sildenafil is a selective pulmonary vasodilator in

lambs with acute pulmonary hypertension. Crit

Care Med 29:1000-1005, 2001.

112. Steinhorn RH, Albert G, Swartz DD, et al: Recombi-

nant human superoxide dismutase enhances the

effect of inhaled nitric oxide in persistent pulmonary

hypertension. Am J Respir Crit Care Med 164:834-

839, 2001.

113. Evgenov OV, Ichinose F, Evgenov NV, et al: Soluble

guanylate cyclase activator reverses acute pulmo-

nary hypertension and augments the pulmonary

vasodilator response to inhaled nitric oxide in

awake lambs. Circulation 110:2253-2259, 2004.

114. Evgenov OV, Kohane DS, Bloch KD, et al: Inhaled

agonists of soluble guanylate cyclase induce selec-

tive pulmonary vasodilation. Am J Respir Crit Care

Med 176:1138-1145, 2007.

115. Lepore JJ, Maroo A, Pereira NL, et al: Effect of sil-

denafil on the acute pulmonary vasodilator res-

ponse to inhaled nitric oxide in adults with primary

pulmonary hypertension. Am J Cardiol 90:677-680,

2002.

116. Lepore JJ, Maroo A, Bigatello LM, et al: Hemodyna-

mic effects of sildenafil in patients with congestive

heart failure and pulmonary hypertension: Combi-

ned administration with inhaled nitric oxide. Chest

127:1647-1653, 2005.

117. Namachivayam P, Theilen U, Butt WW, et al: Silde-

nafil prevents rebound pulmonary hypertension

after withdrawal of nitric oxide in children. Am J

Respir Crit Care Med 174:1042-1047, 2006.

118. McMahon TJ, Doctor A: Extrapulmonary effects of

inhaled nitric oxide: Role of reversible

-nitrosyla-

tion of erythrocytic hemoglobin. Proc Am Thorac

Soc 3:153-160, 2006.

119. Adrie C, Bloch KD, Moreno PR, et al: Inhaled nitric

oxide increases coronary artery patency after

thrombolysis. Circulation 94:1919-1926, 1996.

120. Fox-Robichaud A, Payne D, Hasan SU, et al: Inhaled

NO as a viable antiadhesive therapy for ischemia/

reperfusion injury of distal microvascular beds. J

Clin Invest 101:2497-2505, 1998.

121. Hataishi R, Rodrigues AC, Neilan TG, et al: Inhaled

nitric oxide decreases infarction size and improves

left ventricular function in a murine model of myo-

cardial ischemia-reperfusion injury. Am J Physiol

Heart Circ Physiol 291:H379-H384, 2006.

122. Liu X, Huang Y, Pokreisz P, et al: Nitric oxide inha-

lation improves microvascular flow and decreases

infarction size after myocardial ischemia and reper-

fusion. J Am Coll Cardiol 50:808-817, 2007.

123. Minneci PC, Deans KJ, Zhi H, et al: Hemolysis-

associated endothelial dysfunction mediated by

accelerated NO inactivation by decompartmentali-

zed oxyhemoglobin. J Clin Invest 115:3409-3417,

2005.

124. Schmidt U, Han RO, DiSalvo TG, et al: Cessation of

platelet-mediated cyclic canine coronary occlusion

after thrombolysis by combining nitric oxide inha-

lation with phosphodiesterase-5 inhibition. J Am

Coll Cardiol 37:1981-1988, 2001.

125. Lee JS, Adrie C, Jacob HJ, et al: Chronic inhalation

of nitric oxide inhibits neointimal formation after

balloon-induced arterial injury. Circ Res 78:337-

342, 1996.

126. Neviere R, Guery B, Mordon S, et al: Inhaled NO

reduces leukocyte–endothelial cell interactions and

myocardial dysfunction in endotoxemic rats. Am J

Physiol Heart Circ Physiol 278:H1783-H1790,

2000.

127. Kubes P, Payne D, Grisham MB, et al: Inhaled NO

impacts vascular but not extravascular com-

partments in postischemic peripheral organs. Am J

Physiol 277:H676–H682, 1999.

128. Guery B, Neviere R, Viget N, et al: Inhaled NO

preadministration modulates local and remote

ischemia-reperfusion organ injury in a rat model. J

Appl Physiol 87:47-53, 1999.

129. Gianetti J, Del Sarto P, Bevilacqua S, et al: Supple-

mental nitric oxide and its effect on myocardial

injury and function in patients undergoing cardiac

surgery with extracorporeal circulation. J Thorac

Cardiovasc Surg 127:44-50, 2004.

130. Cannon RO III, Schechter AN, Panza JA, et al:

Effects of inhaled nitric oxide on regional blood

flow are consistent with intravascular nitric oxide

delivery. J Clin Invest 108:279-287, 2001.

131. Hataishi R, Zapol WM, Bloch KD, Ichinose F:

Inhaled nitric oxide does not reduce systemic vas-

cular resistance in mice. Am J Physiol Heart Circ

Physiol 290:H1826–H1829, 2006.

132. Stamler JS, Jaraki O, Osborne J, et al: Nitric oxide

circulates in mammalian plasma primarily as an

-nitroso adduct of serum albumin. Proc Natl Acad

Sci U S A 89:7674-7677, 1992.

133. Scharfstein JS, Keaney JF Jr, Slivka A, et al: In vivo

transfer of nitric oxide between a plasma protein-

bound reservoir and low molecular weight thiols. J

Clin Invest 94:1432-1439, 1994.

134. Gladwin MT, Raat NJ, Shiva S, et al: Nitrite as a

vascular endocrine nitric oxide reservoir that con-

tributes to hypoxic signaling, cytoprotection, and

vasodilation. Am J Physiol Heart Circ Physiol

291:H2026–H2035, 2006.

135. Oda H, Kusumoto S, Nakajima T: Nitrosyl-hemog-

lobin formation in the blood of animals exposed to

nitric oxide. Arch Environ Health 30:453-456,

1975.

136. Yoshida K, Kasama K: Biotransformation of nitric

oxide. Environ Health Perspect 73:201-205, 1987.

137. Ng ES, Jourd’heuil D, McCord JM, et al: Enhanced

-nitroso-albumin formation from inhaled NO

during ischemia/reperfusion. Circ Res 94:559-565,

2004.

138. Duranski MR, Greer JJ, Dejam A, et al: Cytoprotec-

tive effects of nitrite during in vivo ischemia-reper-

fusion of the heart and liver. J Clin Invest

115:1232-1240, 2005.